대체 수의학 시장 규모, 점유율 및 동향 분석 보고서 : 제품 유형별, 동물별, 유형별, 투여 경로별, 유통 채널별, 지역별 및 부문별 예측(2026-2033년)

Alternative Veterinary Medicine Market Summary

The global alternative veterinary medicine market size was estimated at USD 3.2 billion in 2025 and is projected to reach USD 9.3 billion by 2033, growing at a CAGR of 15.3% from 2026 to 2033. The industry is driven by several key factors, including the growing pet population and increasing humanization of pets, which fuels demand for holistic and natural treatments.

Rising awareness among pet owners about the potential side effects of conventional drugs is prompting interest in alternative therapies such as acupuncture, herbal medicine, chiropractic care, and homeopathy. Moreover, according to an article published by AVMA, in May 2025, an estimated 4,000 to 5,000 veterinarians in the U.S. have completed acupuncture certification through recognized institutions such as Chi University, IVAS, CuraCore, CRI, EBVA, and CIVT. The increasing acceptability and incorporation of acupuncture within conventional veterinary treatment is reflected in the expanding number of qualified professionals. The market for alternative veterinary medicine is growing as more veterinarians use these alternative treatment modalities, which increases their credibility and increases pet owners' confidence and desire for holistic care.

Similarly, according to an article published by The Hindu, in October 2024, the newly released Standard Veterinary Treatment Guidelines (SVTG) by the Union Ministry of Animal Husbandry are expected to significantly drive the growth of the alternative veterinary medicine market. These guidelines encourage a move toward Ayurvedic and herbal veterinary medications as safer and more environmental friendly alternatives by attempting to limit and restrict the use of antibiotics in the treatment of livestock and poultry. By increasing farmers' and veterinarians' confidence in conventional formulations, this policy initiative promotes broader use in the commercial and rural animal health sectors. Additionally, Government support for Ayurveda in veterinary care is expected to boost investment, research, and development of herbal and plant-based animal health products. This will help the market grow while encouraging safer, more natural, and environmentally friendly ways to care for animals.

Moreover, the growing preference for holistic and non-invasive treatment approaches among pet owners and livestock producers is another crucial factor driving the alternative veterinary medicine market, as it aligns with increasing awareness of animal wellness, reduced side effects, and sustainable care practices. For instance, according to an article published by The Times of India, in March 2026, the Indian Research and Technology Advancement (IRTA) is actively leading research on Ayurvedic veterinary care, exploring the efficacy of herbal formulations and traditional treatment practices for animal health management. Such initiatives aim to scientifically validate age-old remedies used in livestock and companion animal care, particularly for conditions like infections, inflammation, and metabolic disorders. By bridging traditional knowledge with modern research methodologies, IRTA is helping standardize Ayurvedic veterinary treatments, improve acceptance among practitioners, and support regulatory recognition thereby significantly contributing to the growth of the industry.

Global Alternative Veterinary Medicine Market Report Segmentation

This report forecasts revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2021 to 2033. For this study, Grand View Research has segmented the global alternative veterinary medicine market report based on product, animal, type, route of administration, distribution channel, and region.

• Product Outlook (Revenue, USD Million, 2021 - 2033)
• Pharmaceuticals
  • Antimicrobial
  • Anti-inflammatory
  • Analgesics
  • Others
• Nutritional Supplements
• Feed Additives
• Animal Outlook (Revenue, USD Million, 2021 - 2033)
• Companion Animals
  • Dogs
  • Cats
  • Horses
  • Other Companion Animals
• Production Animals
  • Cattle
  • Poultry
  • Swine
  • Other Production Animals
• Type Outlook (Revenue, USD Million, 2021 - 2033)
• Ayurvedic
• Traditional Chinese Veterinary Medicine (CTM)
• Homeopathic
• Others
• Route Of Administration Outlook (Revenue, USD Million, 2021 - 2033)
• Oral
• Topical
• Others
• Distribution Channel Outlook (Revenue, USD Million, 2021 - 2033)
• Veterinary Hospitals/Clinic Pharmacies
• Retail/Specialty Stores
• E-Commerce
• Others
• Regional Outlook (Revenue, USD Million, 2021 - 2033)
• North America
  • U.S.
  • Canada
  • Mexico
• Europe
  • UK
  • Germany
  • France
  • Italy
  • Spain
  • Denmark
  • Sweden
  • Norway
• Asia Pacific
  • Japan
  • China
  • India
  • Australia
  • Thailand
  • South Korea
• Latin America
  • Brazil
  • Argentina
• Middle East & Africa
  • South Africa
  • UAE
  • Saudi Arabia
  • Kuwait
  • Qatar
  • Oman

Table of Contents

Chapter 1. Methodology and Scope

• 1.1. Market Segmentation and Scope
• 1.2. Segment Definitions
  • 1.2.1. Product
  • 1.2.2. Animal
  • 1.2.3. Type
  • 1.2.4. Route of Administration
  • 1.2.5. Distribution Channel
• 1.3. Research Methodology
• 1.4. Information Procurement
  • 1.4.1. Purchased Database
  • 1.4.2. GVR's Internal Database
  • 1.4.3. Secondary Sources
  • 1.4.4. Primary Research
• 1.5. Information/Data Analysis
  • 1.5.1. Data Analysis Models
• 1.6. Market Formulation & Validation
• 1.7. Model Details
  • 1.7.1. Commodity Flow Analysis
  • 1.7.2. Bottom Up Analysis
  • 1.7.3. Multivariate Analysis
• 1.8. List of Secondary Sources
• 1.9. List of Abbreviations
• 1.10. Objectives

Chapter 2. Executive Summary

• 2.1. Market Outlook
• 2.2. Segment Outlook
• 2.3. Competitive Insights

Chapter 3. Market Variable Trends & Scope

• 3.1. Market Lineage Outlook
  • 3.1.1. Parent Market Outlook
  • 3.1.2. Ancillary/Related Market Outlook
• 3.2. Market Dynamics
  • 3.2.1. Market Driver Analysis
    • 3.2.1.1. Growing Awareness about Side Effects of Conventional Drugs
    • 3.2.1.2. Rising Pet Population & Pet Humanization
    • 3.2.1.3. Technological Advancements in Product Formulations
    • 3.2.1.4. Supportive Government & Institutional Initiatives
  • 3.2.2. Market Restraint Analysis
    • 3.2.2.1. Limited Awareness among Veterinarians & Livestock Owners.
    • 3.2.2.2. Low Product Availability.
  • 3.2.3. Market Opportunity Analysis
  • 3.2.4. Market Challenge Analysis
• 3.3. Pricing Analysis
• 3.4. Disease Prevalence Analysis, 2025
• 3.5. Estimated Animal Population, By Key Species, Key Countries, 2025
• 3.6. Market Analysis Tools
  • 3.6.1. Porter's Five Forces Analysis
  • 3.6.2. PESTEL by SWOT Analysis

Chapter 4. Alternative Veterinary Medicine Market: Product Estimates & Trend Analysis

• 4.1. Segment Dashboard
• 4.2. Alternative Veterinary Medicine Market, By Product Movement Analysis
• 4.3. Alternative Veterinary Medicine Market Estimates & Forecasts, by Product, 2021 to 2033 (USD Million)
• 4.4. Pharmaceuticals
  • 4.4.1. Pharmaceuticals Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 4.4.2. Antimicrobial
    • 4.4.2.1. Antimicrobial Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 4.4.3. Anti-inflammatory
    • 4.4.3.1. Anti-inflammatory Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 4.4.4. Analgesics
    • 4.4.4.1. Analgesics Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 4.4.5. Others
    • 4.4.5.1. Others Market Estimates and Forecasts, 2021 - 2033 (USD Million)
• 4.5. Nutritional Supplements
  • 4.5.1. Nutritional Supplements Market Estimates and Forecasts, 2021 - 2033 (USD Million)
• 4.6. Feed Additives
  • 4.6.1. Feed Additives Market Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 5. Alternative Veterinary Medicine Market: Animal Estimates & Trend Analysis

• 5.1. Segment Dashboard
• 5.2. Alternative Veterinary Medicine Market, By Animal Movement Analysis
• 5.3. Alternative Veterinary Medicine Market Estimates & Forecasts, by Animal, 2021 to 2033 (USD Million)
• 5.4. Companion Animal
  • 5.4.1. Companion Animal Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 5.4.2. Dogs
    • 5.4.2.1. Dogs Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 5.4.3. Cats
    • 5.4.3.1. Cats Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 5.4.4. Horses
    • 5.4.4.1. Horses Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 5.4.5. Other Companion Animals
    • 5.4.5.1. Other Companion Animals Market Estimates and Forecasts, 2021 - 2033 (USD Million)
• 5.5. Production Animal
  • 5.5.1. Production Animal Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 5.5.2. Cattle
    • 5.5.2.1. Cattle Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 5.5.3. Poultry
    • 5.5.3.1. Poultry Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 5.5.4. Swine
    • 5.5.4.1. Swine Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 5.5.5. Other Production Animals
    • 5.5.5.1. Other Production Animals Market Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 6. Alternative Veterinary Medicine Market: By Type Estimates & Trend Analysis

• 6.1. Segment Dashboard
• 6.2. Alternative Veterinary Medicine Market, By Type Movement Analysis
• 6.3. Alternative Veterinary Medicine Market Estimates & Forecasts, By Type, 2021 to 2033 (USD Million)
• 6.4. Ayurvedic
  • 6.4.1. Ayurvedic Market Estimates and Forecasts, 2021 - 2033 (USD Million)
• 6.5. Traditional Chinese Veterinary Medicine (CTM)
  • 6.5.1. Traditional Chinese veterinary Medicine (CTM) Market Estimates and Forecasts, 2021 - 2033 (USD Million)
• 6.6. Homeopathic
  • 6.6.1. Homeopathic Market Estimates and Forecasts, 2021 - 2033 (USD Million)
• 6.7. Others
  • 6.7.1. Others Market Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 7. Alternative Veterinary Medicine Market: By Route of Administration Estimates & Trend Analysis

• 7.1. Segment Dashboard
• 7.2. Alternative Veterinary Medicine Market, By Route of Administration Movement Analysis
• 7.3. Alternative Veterinary Medicine Market Estimates & Forecasts, By Route of Administration, 2021 to 2033 (USD Million)
• 7.4. Oral
  • 7.4.1. Oral Market Estimates and Forecasts, 2021 - 2033 (USD Million)
• 7.5. Topical
  • 7.5.1. Topical Market Estimates and Forecasts, 2021 - 2033 (USD Million)
• 7.6. Others
  • 7.6.1. Others Market Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 8. Alternative Veterinary Medicine Market: By Distribution Channel Estimates & Trend Analysis

• 8.1. Segment Dashboard
• 8.2. Alternative Veterinary Medicine Market, By Distribution Channel Movement Analysis
• 8.3. Alternative Veterinary Medicine Market Estimates & Forecasts, by Distribution Channel, 2021 to 2033 (USD Million)
  • 8.3.1. Veterinary Hospitals/Clinic Pharmacies
    • 8.3.1.1. Veterinary Hospitals/Clinic Pharmacies Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 8.3.2. E-Commerce
    • 8.3.2.1. E-Commerce Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 8.3.3. Retail/Specialty Stores
    • 8.3.3.1. Retail/Specialty Stores Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 8.3.4. Others
    • 8.3.4.1. Others Market Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 9. Alternative Veterinary Medicine Market: By Regional Estimates & Trend Analysis

• 9.1. Region Market Dashboard
• 9.2. Region Market Share Analysis, 2025 & 2033
• 9.3. North America
  • 9.3.1. North America Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 9.3.2. U.S
    • 9.3.2.1. Key Country Dynamics
    • 9.3.2.2. Competitive Scenario
    • 9.3.2.3. Regulatory Framework
    • 9.3.2.4. U.S. Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 9.3.3. Canada
    • 9.3.3.1. Key Country Dynamics
    • 9.3.3.2. Competitive Scenario
    • 9.3.3.3. Regulatory Framework
    • 9.3.3.4. Canada Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 9.3.4. Mexico
    • 9.3.4.1. Key Country Dynamics
    • 9.3.4.2. Competitive Scenario
    • 9.3.4.3. Regulatory Framework
    • 9.3.4.4. Mexico Market Estimates and Forecasts, 2021 - 2033 (USD Million)
• 9.4. Europe
  • 9.4.1. Europe Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 9.4.2. UK
    • 9.4.2.1. Key Country Dynamics
    • 9.4.2.2. Competitive Scenario
    • 9.4.2.3. Regulatory Framework
    • 9.4.2.4. UK Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 9.4.3. Germany
    • 9.4.3.1. Key Country Dynamics
    • 9.4.3.2. Competitive Scenario
    • 9.4.3.3. Regulatory Framework
    • 9.4.3.4. Germany Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 9.4.4. France
    • 9.4.4.1. Key Country Dynamics
    • 9.4.4.2. Competitive Scenario
    • 9.4.4.3. Regulatory Framework
    • 9.4.4.4. France Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 9.4.5. Italy
    • 9.4.5.1. Key Country Dynamics
    • 9.4.5.2. Competitive Scenario
    • 9.4.5.3. Regulatory Framework
    • 9.4.5.4. Italy Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 9.4.6. Spain
    • 9.4.6.1. Key Country Dynamics
    • 9.4.6.2. Competitive Scenario
    • 9.4.6.3. Regulatory Framework
    • 9.4.6.4. Spain Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 9.4.7. Denmark
    • 9.4.7.1. Key Country Dynamics
    • 9.4.7.2. Competitive Scenario
    • 9.4.7.3. Regulatory Framework
    • 9.4.7.4. Denmark Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 9.4.8. Sweden
    • 9.4.8.1. Key Country Dynamics
    • 9.4.8.2. Competitive Scenario
    • 9.4.8.3. Regulatory Framework
    • 9.4.8.4. Sweden Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 9.4.9. Norway
    • 9.4.9.1. Key Country Dynamics
    • 9.4.9.2. Competitive Scenario
    • 9.4.9.3. Regulatory Framework
    • 9.4.9.4. Norway Market Estimates and Forecasts, 2021 - 2033 (USD Million)
• 9.5. Asia Pacific
  • 9.5.1. Asia Pacific Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 9.5.2. Japan
    • 9.5.2.1. Key Country Dynamics
    • 9.5.2.2. Competitive Scenario
    • 9.5.2.3. Regulatory Framework
    • 9.5.2.4. Japan Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 9.5.3. China
    • 9.5.3.1. Key Country Dynamics
    • 9.5.3.2. Competitive Scenario
    • 9.5.3.3. Regulatory Framework
    • 9.5.3.4. China Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 9.5.4. India
    • 9.5.4.1. Key Country Dynamics
    • 9.5.4.2. Competitive Scenario
    • 9.5.4.3. Regulatory Framework
    • 9.5.4.4. India Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 9.5.5. Australia
    • 9.5.5.1. Key Country Dynamics
    • 9.5.5.2. Competitive Scenario
    • 9.5.5.3. Regulatory Framework
    • 9.5.5.4. Australia Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 9.5.6. Thailand
    • 9.5.6.1. Key Country Dynamics
    • 9.5.6.2. Competitive Scenario
    • 9.5.6.3. Regulatory Framework
    • 9.5.6.4. Thailand Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 9.5.7. South Korea
    • 9.5.7.1. Key Country Dynamics
    • 9.5.7.2. Competitive Scenario
    • 9.5.7.3. Regulatory Framework
    • 9.5.7.4. South Korea Market Estimates and Forecasts, 2021 - 2033 (USD Million)
• 9.6. Latin America
  • 9.6.1. Latin America Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 9.6.2. Brazil
    • 9.6.2.1. Key Country Dynamics
    • 9.6.2.2. Competitive Scenario
    • 9.6.2.3. Regulatory Framework
    • 9.6.2.4. Brazil Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 9.6.3. Argentina
    • 9.6.3.1. Key Country Dynamics
    • 9.6.3.2. Competitive Scenario
    • 9.6.3.3. Regulatory Framework
    • 9.6.3.4. Argentina Market Estimates and Forecasts, 2021 - 2033 (USD Million)
• 9.7. MEA
  • 9.7.1. MEA Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 9.7.2. South Africa
    • 9.7.2.1. Key Country Dynamics
    • 9.7.2.2. Competitive Scenario
    • 9.7.2.3. Regulatory Framework
    • 9.7.2.4. South Africa Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 9.7.3. UAE
    • 9.7.3.1. Key Country Dynamics
    • 9.7.3.2. Competitive Scenario
    • 9.7.3.3. Regulatory Framework
    • 9.7.3.4. UAE Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 9.7.4. Saudi Arabia
    • 9.7.4.1. Key Country Dynamics
    • 9.7.4.2. Competitive Scenario
    • 9.7.4.3. Regulatory Framework
    • 9.7.4.4. Saudi Arabia Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 9.7.5. Kuwait
    • 9.7.5.1. Key Country Dynamics
    • 9.7.5.2. Competitive Scenario
    • 9.7.5.3. Regulatory Framework
    • 9.7.5.4. Kuwait Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 9.7.6. Qatar
    • 9.7.6.1. Key Country Dynamics
    • 9.7.6.2. Competitive Scenario
    • 9.7.6.3. Regulatory Framework
    • 9.7.6.4. Qatar Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 9.7.7. Oman
    • 9.7.7.1. Key Country Dynamics
    • 9.7.7.2. Competitive Scenario
    • 9.7.7.3. Regulatory Framework
    • 9.7.7.4. Oman Market Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 10. Competitive Landscape

• 10.1. Market Participant Categorization
  • 10.1.1. Market Leaders
  • 10.1.2. Emerging Players
• 10.2. Market Share/Assessment Analysis, 2025 (Heat Map Analysis)
• 10.3. Company Profiles
  • 10.3.1. Himalaya Wellness Company
    • 10.3.1.1. Participant's Overview
    • 10.3.1.2. Financial Performance
    • 10.3.1.3. Product Benchmarking
    • 10.3.1.4. Strategic Initiatives
  • 10.3.2. Alicanto Vetcare
    • 10.3.2.1. Participant's Overview
    • 10.3.2.2. Financial Performance
    • 10.3.2.3. Product Benchmarking
    • 10.3.2.4. Strategic Initiatives
  • 10.3.3. Natural Remedies
    • 10.3.3.1. Participant's Overview
    • 10.3.3.2. Financial Performance
    • 10.3.3.3. Product Benchmarking
    • 10.3.3.4. Strategic Initiatives
  • 10.3.4. Zenex Health Animal Health
    • 10.3.4.1. Participant's Overview
    • 10.3.4.2. Financial Performance
    • 10.3.4.3. Product Benchmarking
    • 10.3.4.4. Strategic Initiatives
  • 10.3.5. AYURSUN PHARMA
    • 10.3.5.1. Participant's Overview
    • 10.3.5.2. Financial Performance
    • 10.3.5.3. Product Benchmarking
    • 10.3.5.4. Strategic Initiatives
  • 10.3.6. GreenVet
    • 10.3.6.1. Participant's Overview
    • 10.3.6.2. Financial Performance
    • 10.3.6.3. Product Benchmarking
    • 10.3.6.4. Strategic Initiatives
  • 10.3.7. INDIAN HERBS
    • 10.3.7.1. Participant's Overview
    • 10.3.7.2. Financial Performance
    • 10.3.7.3. Product Benchmarking
    • 10.3.7.4. Strategic Initiatives
  • 10.3.8. INDIAN GENOMIX (P) LTD
    • 10.3.8.1. Participant's Overview
    • 10.3.8.2. Financial Performance
    • 10.3.8.3. Product Benchmarking
    • 10.3.8.4. Strategic Initiatives
  • 10.3.9. AMORVET
    • 10.3.9.1. Participant's Overview
    • 10.3.9.2. Financial Performance
    • 10.3.9.3. Product Benchmarking
    • 10.3.9.4. Strategic Initiatives
  • 10.3.10. NU Alter Remedies
    • 10.3.10.1. Participant's Overview
    • 10.3.10.2. Financial Performance
    • 10.3.10.3. Product Benchmarking
    • 10.3.10.4. Strategic Initiatives